Schedule/Programme 2011
Click here to download program in pdf-format
Monday September 5
Session 1. Keynote speakers
Chair: Erik Boye
1700 Opening, Welcome
1715 Bruce Alberts, Keynote Lecture
A Much Deeper Understanding of Cells will be Crucial for BioMedicine
1800 Tim Hunt, Dentist Aase Lecture
Switches and Latches in the Control of Cell Division
1900 Poster Mounting
1930 Buffet dinner in Dragebygget (the Dragon Building)
Tuesday September 6
Breakfast
Session 2. Basic mechanisms of cell-cycle transitions
Chair: Kirsten Skarstad
0830 John Diffley
Early Events in Eukaryotic DNA Replication
0910 Jan M. Skotheim
Dynamics of cell-cycle control
0950 Harald Stenmark
Studies of a lipid kinase reveal the roles of membrane dynamics in
tumour suppression
1030 Coffee break
Session 3. Tumor hypoxia and glucose metabolism
Chair: Geoffrey Shapiro
1100 Peter J. Ratcliffe
Hypoxia signalling pathways: insights from and into cancer
1140 Constantinos Koumanis
Activation of the Integrated Stress Response (ISR) is required for adaptation of tumor cells to hypoxic and nutrient stress and contributes to tumor growth and metastasis
1220 Ming Tan
Overcoming Cancer Therapeutic Resistance by Targeting Dysregulated Glucose
Metabolism
1300 Lunch
1400 Poster session
1700 Departure for Fjord Excursion and Dinne
Wednesday September 7
Breakfast
Session 4. Checkpoints
Chair: Randi Syljuåsen
0830 Jonathon Pines
The control of mitosis through the Spindle Assembly Checkpoint and the APC/C
0910 Helen Piwnica-Worms
Targeting Chk1 in p53-deficient triple negative Breast Cancer using human in Mouse Tumor Models
0950 Trond Stokke
Checkpoints in the G2 phase of the cell cycle after acute induction of double-strand breaks by ionizing radiation
1010 Grete Hasvold
Targeting hypoxic cancer cells by inhibition of CHK1
1030 Coffee Break and posters
Session 5. Protein kinases in cell-cycle control
Chair: Jonathon Pines
1100 Geoffrey Shapiro
Cyclin-Dependent Kinases as Targets for Cancer Treatment
1140 Arvin Dar
New Insights into Kinase Signaling Pathways Using Chemical Genetics
1220 Beata Grallert
Coupling of growth and the cell cycle in fission yeast
1240 Jorrit Enserink
A chemical-genetic screen to unravel the genetic network of CDC28/CDK1 reveals a
role for the Rad6-Bre1 pathway in cell cycle progression
1300 Lunch
Session 6. Exploiting metabolic pathways for cancer treatment
Chair: David Shore
1430 Steven McKnight
Targeted Killing of a Cell Based Upon its Unique Metabolic Addiction
1510 Eyal Gottlieb
Metabolic network approaches for cancer therapy
1550 Rolf Bjerkvig
Antivascular therapy new insights.
1630 Posters and coffee
1930 Banquet in Saga Hall
Thursday September 8
Breakfast
Session 7. Basic mechanisms of tumor metabolism
Chair: Stephen McKnight
0830 Nahum Sonenberg
Translational control of cancer
0910 David Shore, The EMBO Lecture
Transcriptional regulation in the ribosome biogenesis network and its connections with telomere biology in the budding yeast S. cerevisiae
0950 Ian G. Mills
The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis
1010 Stephanos Pavlides
The Autophagic Tumor Stroma of Cancer Metabolism - A new model for cancer
1030 Coffee break and posters
Session 8. Cell-cycle regulation
Chair: Trond Stokke
1100 Ross D. Hannan
Inhibition of RNA Polymerase I as a Therapeutic Strategy for Cancer-Specific Activation of p53
1120 Lorenzo Montanaro
JHDM1B down-regulation stimulates ribosome biogenesis and activates a p53 and SMAD-dependent growth arrest response
1140 Helen J. Whalley
The Role and Regulation of Tiam1-Rac signaling in mitosis
1200 Alberto Gandarillas
Cyclin E switches keratinocyte growth into differentiation
1220 End of meeting
1300 Lunch and departure